Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes

被引：7
|
作者：
Lee, J. -Y. [1 ,2 ]
Cho, Y. [1 ,2 ]
Lee, M. [1 ,2 ]
Lee, Y. -H. [1 ,2 ,3 ]
Lee, B. -W. [1 ,2 ,3 ]
Kang, E. S. [1 ,2 ,3 ]
Cha, B. -S. [1 ,2 ,3 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Grad Sch, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Inst Endocrine Res, Coll Med, Seoul, South Korea
来源：
DIABETES & METABOLISM | 2018年 / 44卷 / 05期
关键词：
INSULIN-RESISTANCE; DOUBLE-BLIND; PIOGLITAZONE; TOLERABILITY; METFORMIN; THERAPY; VILDAGLIPTIN; MONOTHERAPY; 24-WEEK;
D O I：
10.1016/j.diabet.2017.11.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：452 / 455
页数：4
相关论文
共 50 条
  • [31] Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents
    Dandona, P
    Aljada, A
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2004, 18 (02) : 91 - 102
  • [32] Thiazolidinedione use in elderly patients with type 2 diabetes: with and without heart failure
    Seong, Jong-Mi
    Choi, Nam-Kyong
    Jung, Sun-Young
    Chang, Yoosoo
    Kim, Ye-Jee
    Lee, Joongyub
    Park, Byung-Joo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (04) : 344 - 350
  • [33] Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
    Joonsang Yoo
    Jimin Jeon
    Minyoul Baik
    Jinkwon Kim
    Cardiovascular Diabetology, 22
  • [34] Thiazolidinedione derivatives as novel GPR120 agonists for the treatment of type 2 diabetes
    Wang, Xuekun
    Ji, Guoxia
    Han, Xinyu
    Hao, Huiran
    Liu, Wenjing
    Xue, Qidi
    Guo, Qinghua
    Wang, Shiben
    Lei, Kang
    Liu, Yadi
    RSC ADVANCES, 2022, 12 (10) : 5732 - 5742
  • [35] R483, a novel thiazolidinedione, improves glycemia and is well tolerated in healthy subjects and patients with type 2 diabetes
    Weber, C
    Kuhn, B
    Fotteler, B
    DIABETES, 2004, 53 : A484 - A484
  • [36] Thiazolidinedione and cardiovascular risk in type 2 diabetes mellitus
    Yenny
    UNIVERSA MEDICINA, 2008, 27 (04) : 183 - 193
  • [37] SAFETY AND EFFICACY OF LIRAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES AND OBESITY IN CLINICAL PRACTICE
    Dieguez, M.
    Riestra, M.
    Manjon, L.
    Veiguela, B.
    Tuson, C.
    Meana, A.
    Menendez, P.
    Blanco, M. J.
    Casal, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A130 - A130
  • [38] Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes
    Cho, Yun Kyung
    Lee, Jiwoo
    Kang, Yu Mi
    Yoo, Jee Hee
    Park, Joong-Yeol
    Jung, Chang Hee
    Lee, Woo Je
    PLOS ONE, 2019, 14 (08):
  • [39] Efficacy and safety of ezetimibe coadministered with simvastatin versus simvastatin alone in thiazolidinedione-treated patients with type 2 diabetes mellitus
    Gaudiani, L
    Lewin, A
    Meneghini, L
    Perevozskaya, I
    Tobert, J
    Plotkin, D
    Mitchel, Y
    Shah, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 479A - 479A
  • [40] Enhanced Outcomes in Type 2 Diabetes Patients With Acute Kidney Disease Through Thiazolidinedione
    Chang, Li-Yang
    Liao, Hung-Wei
    Chen, Jui-Yi
    Wu, Vin-Cent
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
12345